3D-Printed Portable Coffin-Like Capsule for Use in Assisted Suicide Granted Approval in Switzerland
By HospiMedica International staff writers Posted on 07 Dec 2021 |
A 3D-printed capsule designed for use in assisted suicide may legally be operated in Switzerland.
Exit International (Darwin, Australia) has developed the ‘Sarco’ machine which offers a different approach for a peaceful death, without the need for controlled substances. Some 1,300 people died by assisted suicide in Switzerland in 2020 using the services of the country’s two largest assisted suicide organizations. The method currently in use is ingestion of liquid sodium pentobarbital. In contrast, the coffin-like Sarco capsule is activated from the inside by the person intending to die by flooding the interior with nitrogen, rapidly reducing the oxygen level to 1% from 21%. The person feels slightly disoriented and euphoric before losing consciousness. Death takes place through hypoxia and hypocapnia, oxygen and carbon dioxide deprivation, respectively. There is no panic, no choking feeling and the whole process takes about 30 seconds.
Currently, a doctor or doctors need to be involved to prescribe the sodium pentobarbital and to confirm the person’s mental capacity. Sarco aims to remove any kind of psychiatric review from the process and allow the individual to control the method themselves. They will be asked a number of questions and when they have answered, they may press the button inside the capsule activating the mechanism in their own time. The company aims to develop an artificial intelligence screening system to establish the person’s mental capacity and its original conceptual idea is that the person would do an online test and receive a code to access the Sarco.
“Last year, we sought senior advice on the legality of using Sarco in Switzerland for assisted dying and were pleased when the Sarco suicide capsule ‘passes legal review’ in Switzerland,” Dr. Philip Nitschke, founder of Exit International said to SWI swissinfo.ch. “This review has been completed and we’re very pleased with the result which found that we hadn’t overlooked anything. There are no legal issues at all.”
Related Links:
Exit International
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration